ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.79155
-0.03%
Brent Oil
84.245
-0.09%
Bitcoin
68,422.14
0.19%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Scynexis Inc (SCYX)

  7. Scynexis Inc (SCYX) Noticias

SCYX

Scynexis (SCYX)

Scynexis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SCYX
FechaHoraFuenteTítuloSímboloCompañía
08/05/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCYXScynexis Inc
16/02/202416:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCYXScynexis Inc
13/02/202420:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCYXScynexis Inc
05/01/202408:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCYXScynexis Inc
28/11/202315:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCYXScynexis Inc
27/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCYXScynexis Inc
13/11/202316:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SCYXScynexis Inc
27/09/202319:31GlobeNewswire Inc.SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substanceNASDAQ:SCYXScynexis Inc
18/07/202315:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SCYXScynexis Inc
23/06/202315:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCYXScynexis Inc
23/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCYXScynexis Inc
09/06/202315:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCYXScynexis Inc
01/05/202315:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SCYXScynexis Inc
01/05/202315:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCYXScynexis Inc
01/05/202315:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SCYXScynexis Inc
03/04/202307:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCYXScynexis Inc
31/03/202306:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SCYXScynexis Inc
31/03/202306:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCYXScynexis Inc
30/03/202309:43Dow Jones NewsScynexis Shares Jump 60% After Licensing Deal With GSKNASDAQ:SCYXScynexis Inc
02/12/202212:15TipRanksMaxim Group Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
02/12/202205:45TipRanksSCYNEXIS (SCYX) Receives a Buy from Ladenburg Thalmann & Co.NASDAQ:SCYXScynexis Inc
10/11/202211:20TipRanksAnalysts’ Top Healthcare Picks: Larimar Therapeutics (LRMR), SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
10/11/202205:45TipRanksLadenburg Thalmann & Co. Reaffirms Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
26/10/202215:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SCYXScynexis Inc
26/10/202214:41TipRanksAnalysts Offer Insights on Healthcare Companies: Immunic (IMUX), SCYNEXIS (SCYX) and Karuna Therapeutics (KRTX)NASDAQ:SCYXScynexis Inc
16/08/202212:40TipRanksAnalysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Clene (CLNN)NASDAQ:SCYXScynexis Inc
16/08/202205:05TipRanksH.C. Wainwright Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
15/08/202220:05TipRanksBrookline Capital Markets Keeps Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
15/08/202215:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCYXScynexis Inc
01/08/202212:31TipRanksAnalysts Are Bullish on Top Healthcare Stocks: SCYNEXIS (SCYX), Concert Pharma (CNCE)NASDAQ:SCYXScynexis Inc
 Showing the most relevant articles for your search:NASDAQ:SCYX

Su Consulta Reciente

LSE
SV99
Mitsu Hc Cap.23
USOTC
ARNMF
ARN Media (PK)
BIT
SMETL5
Societe Generale Effekten
EU
RAUVF
Region Auvergne-rhones-a...
EU
BE6337553588
Royal Balconies of Menor...
CRTO
BRZUSDT
Brazilian Digital Token
USOTC
ATBSF
Autobacs Seven (PK)
AMEX
JHSC
John Hancock Multifactor...
EU
Y558S
Y558S
EU
A157T
A157T
LSE
QK30
Morg.st.b.v 24
BOV
BGRT39M
GLOBAL REIT DRN
NASDAQ
FNVTW
Finnovate Acquisition
AMEX
NBCC
Neuberger Berman Next Ge...
COIN
WATTUST
WATTTON
EU
P998S
P998S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados